Floudas C, Sarkizova S, Ceccarelli M, Zheng W
J Immunother Cancer. 2025; 13(1).
PMID: 39848687
PMC: 11784169.
DOI: 10.1136/jitc-2024-010569.
Albutti A
Cancer Rep (Hoboken). 2024; 7(12):e70079.
PMID: 39651594
PMC: 11626413.
DOI: 10.1002/cnr2.70079.
Sheikhlary S, Lopez D, Moghimi S, Sun B
Biomolecules. 2024; 14(4).
PMID: 38672519
PMC: 11048403.
DOI: 10.3390/biom14040503.
Xiang Y, Liu X, Wang Y, Zheng D, Meng Q, Jiang L
Front Immunol. 2024; 15:1366260.
PMID: 38655260
PMC: 11035781.
DOI: 10.3389/fimmu.2024.1366260.
Singh A, Malviya R, Prajapati B, Singh S, Goyal P
J Funct Biomater. 2023; 14(5).
PMID: 37233357
PMC: 10219237.
DOI: 10.3390/jfb14050247.
Vaccines as treatments for prostate cancer.
Rastogi I, Muralidhar A, McNeel D
Nat Rev Urol. 2023; 20(9):544-559.
PMID: 36879114
PMC: 9987387.
DOI: 10.1038/s41585-023-00739-w.
Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics.
Le I, Dhandayuthapani S, Chacon J, Eiring A, Gadad S
Vaccines (Basel). 2022; 10(5).
PMID: 35632572
PMC: 9146235.
DOI: 10.3390/vaccines10050816.
Biomedical polymers: synthesis, properties, and applications.
Chen W, Chen Q, Chen Q, Cui C, Duan S, Kang Y
Sci China Chem. 2022; 65(6):1010-1075.
PMID: 35505924
PMC: 9050484.
DOI: 10.1007/s11426-022-1243-5.
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
Naimi A, Mohammed R, Raji A, Chupradit S, Valerievich Yumashev A, Suksatan W
Cell Commun Signal. 2022; 20(1):44.
PMID: 35392976
PMC: 8991803.
DOI: 10.1186/s12964-022-00854-y.
Cancer combination therapies by angiogenesis inhibitors; a comprehensive review.
Javed Ansari M, Bokov D, Markov A, Turki Jalil A, Shalaby M, Suksatan W
Cell Commun Signal. 2022; 20(1):49.
PMID: 35392964
PMC: 8991477.
DOI: 10.1186/s12964-022-00838-y.
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier.
Vafaei S, Zekiy A, Khanamir R, Zaman B, Ghayourvahdat A, Azimizonuzi H
Cancer Cell Int. 2022; 22(1):2.
PMID: 34980128
PMC: 8725311.
DOI: 10.1186/s12935-021-02407-8.
Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.
Tay B, Wright Q, Ladwa R, Perry C, Leggatt G, Simpson F
Vaccines (Basel). 2021; 9(5).
PMID: 34065557
PMC: 8160852.
DOI: 10.3390/vaccines9050535.
Engineered Cell-Membrane-Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity.
Jiang Y, Krishnan N, Zhou J, Chekuri S, Wei X, Kroll A
Adv Mater. 2020; 32(30):e2001808.
PMID: 32538494
PMC: 7669572.
DOI: 10.1002/adma.202001808.
Identification and Design of a Next-Generation Multi Epitopes Bases Peptide Vaccine Candidate Against Prostate Cancer: An In Silico Approach.
Patra P, Bhattacharya M, Sharma A, Ghosh P, Sharma G, Patra B
Cell Biochem Biophys. 2020; 78(4):495-509.
PMID: 32347457
DOI: 10.1007/s12013-020-00912-7.
Liver Cancer: Current and Future Trends Using Biomaterials.
Chew S, Moscato S, George S, Azimi B, Danti S
Cancers (Basel). 2020; 11(12).
PMID: 31888198
PMC: 6966667.
DOI: 10.3390/cancers11122026.
The evolving role of immuno-oncology for the treatment of head and neck cancer.
Strome A, Zhang X, Strome S
Laryngoscope Investig Otolaryngol. 2019; 4(1):62-69.
PMID: 30828620
PMC: 6383301.
DOI: 10.1002/lio2.235.
Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10.
Llopiz D, Ruiz M, Silva L, Sarobe P
Front Immunol. 2018; 9:1923.
PMID: 30233565
PMC: 6129595.
DOI: 10.3389/fimmu.2018.01923.
Extra-Large Pore Mesoporous Silica Nanoparticles Enabling Co-Delivery of High Amounts of Protein Antigen and Toll-like Receptor 9 Agonist for Enhanced Cancer Vaccine Efficacy.
Cha B, Jeong J, Kim J
ACS Cent Sci. 2018; 4(4):484-492.
PMID: 29721531
PMC: 5920615.
DOI: 10.1021/acscentsci.8b00035.
High Antigen Processing Machinery component expression in Langerhans cells from melanoma patients' sentinel lymph nodes.
Romoli M, Di Gennaro P, Gerlini G, Sestini S, Brandani P, Ferrone S
Cell Immunol. 2017; 320:29-37.
PMID: 28870403
PMC: 8711770.
DOI: 10.1016/j.cellimm.2017.08.007.
Immunologic responses to a novel DNA vaccine targeting human papillomavirus-11 E6E7.
Ahn J, Peng S, Hung C, Roden R, Wu T, Best S
Laryngoscope. 2017; 127(12):2713-2720.
PMID: 28714529
PMC: 5687988.
DOI: 10.1002/lary.26737.
